Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Metformin HCL in Patients With Type 2 Diabetes Intensively Treated With Insulin: a Treatment Strategy for Insulin Resistance in Type 2 Diabetes Mellitus: a Randomized Controlled Trial

NCT00375388 is registered in ClinicalTrials.gov with Bethesda General Hospital, Hoogeveen as lead sponsor.

NCT NCT00375388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00375388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Metformin HCL in Patients With Type 2 Diabetes Intensively Treated With Insulin: a Treatment Strategy for Insulin Resistance in Type 2 Diabetes Mellitus: a Randomized Controlled Trial
Lead sponsor
Bethesda General Hospital, Hoogeveen
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1998
Completion date
October 31, 2002
Enrollment
400
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus